Immunic (NASDAQ:IMUX) Downgraded by Zacks Investment Research to “Sell” – Riverton Roll
Immunic (NASDAQ:IMUX) Downgraded by Zacks Investment Research to “Sell” Riverton Roll
Zacks Investment Research lowered shares of Immunic (NASDAQ:IMUX) from a hold rating to a sell rating in a research report report published on Saturday …
Source: Investment New Feed